Genetic predisposition to ocular melanoma

Eye

Volumn 13, Issue 1, 1999, Pages 43-46

  Houlston, R S ^a   Damato, B E ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

BRCA2; CDKN2; Genetics; Ocular melanoma

Indexed keywords

BRCA2 PROTEIN; PROTEIN P16;

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; DISEASE ASSOCIATION; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; MELANOMA; ONCOGENE; OVARY CANCER; UVEA MELANOMA;

EID: 0032996193     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1999.9     Document Type: Article

References (58)

1. Osterlind A. Trends in incidence of ocular malignant melanoma in Denmark 1943-1982. Int J Cancer 1987;40:161-4.
2. Swerdlow AJ. Epidemiology of melanoma of the eye in the Oxford Region, 1952-78. Br J Cancer 1983;47:311-3.
3. Parkin DM, Muir CS, Whelan LB, et al. Cancer incidence in five countries. Vol VI. Lyon: International Agency for Research on Cancer, 1992.
4. Jensen OA, Prause JV. Malignant melanomas of the human uvea in Denmark: incidence and 25-year follow up of cases diagnosed between 1943 and 1952. In: Lommadsch PK, Blodi FC. Intraocular tumors. New York: Springer-Verlag, 1983:85-92.
5. Polednak AP, Flannery JT. Brain, other central nervous system, and eye cancer. Cancer 1995;75(Suppl 1):330-7.
6. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1988;32:239-51.
7. Shields JA, Shields CL. Intraocular tumors: a text and atlas. Philadelphia: WB Saunders, 1992:45-69.
8. Singh AD, Donoso LA. Genetic aspects of uveal melanoma. In: Shields JA, editor. Update on malignant ocular tumours. Int Ophthalmol Clin 1993;33:47-52.
9. La Vecchia C, Lucchini F, Negri E, Boyle P, Maisonneuve P, Levi F. Trends of cancer mortality in Europe, 1955-1989. IV. Urinary tract, eye, brain and nerves, and thyroid. Eur J Cancer 1992;28A:1210-81.
10. Strickland D, Lee JA. Melanomas of eye: stability of rates. Am J Epidemiol 1981;113:700-2.
11. Raivio I. Uveal melanoma in Finland: an epidemiological, clinical, histological and prognostic study. Acta Ophthalmol Suppl 1977;133:1-64.
12. IARC monographs on the evaluation of carcinogenic risks to humans vol 55. Solar and ultraviolet radiation. Lyon: IARC, 1992.
13. Tucker MA, Shields JA, Hartge P, Augsburger J, Hoover RN, Fraumeni JF Jr. Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med 1985;313:789-92.
14. Tucker MA, Hartge P, Shields JA. Epidemiology of intraocular melanoma. Recent Results Cancer Res 1986;102:159-65.
15. Seddon JM, Gragoudas ES, Glynn RJ, Egan KM, Albert DM, Blitzer PH. Host factors, UV radiation, and risk of uveal melanoma: a case control study. Arch Ophthalmol 1990;108:1274-80.
16. Holly EA, Aston DA, Char DH, Kristiansen JJ, Ahn DK. Uveal melanoma in relation to ultraviolet light exposure and host factors. Cancer Res 1990;50:5773-7.
17. Scotto J, Fraumeni JF Jr, Lee JA. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst 1976;56:489-91.
18. Silcock AQ. Hereditary sarcoma of the eyeball. Trans Pathol Soc Lond 1892;43:140-1.
19. Canning CR, Hungerford J. Familial uveal melanoma. Br J Ophthalmol 1988;72:241-3.
20. Singh AD, Shields CL, De Potter P, Shields JA, Trock B, Cater J, Pastore D. Familial uveal melanoma: clinical observations on 56 patients. Arch Ophthalmol 1996;114:392-9.
21. Spe TW. Uveal malignant melanoma and von Recklinghausen's neurofibromatosis. Cancer 1988;62:812-7.
22. Kedem A, Even Paz Z, Freund M. Basal cell nevus syndrome associated with malignant melanoma of the iris. Dermatologica 1970;140:99-106.
23. Singh AD, Wang MX, Donoso LA, Shields CL, Potter PD, Shields JA, et al. Familial uveal melanoma. III. Is the occurrence of familial uveal melanoma coincidental? Arch Ophthalmol 1996;114:1101-4.
24. Prause JV, Jensen OA, Eisgart F, Hansen WW, Kieffer M. Bilateral diffuse malignant melanoma of the uvea associated with large cell carcinoma, giant cell type of the lung. Ophthalmologica 1984;189:221-8.
25. Serogard S, Daunius C, Popovic V. Two cases of primary bilateral malignant melanoma of the choroid. Br J Ophthalmol 1988;72:244-5.
26. Zygulska-March H, Slomska J, Heitzrnan J. Szesc prypadkow obuocznego czerniaka blong naczyniowej. Klin Ocza 1992;94:157-8.
27. Schammas HF, Watzke RC. Bilateral choroidal melanomas. AMA Arch Ophthalmol 1977;95:617-23.
28. Jay M, McCartney AC. Familial malignant melanoma of the uvea and p53: a Victorian detective story. Surv Ophthalmol 1993;37:457-62.
29. Mullaney J, Mooney D, O'Connor M, McDonald GS. Bilateral ovarian carcinoma with bilateral uveal melanoma. Br J Ophthalmol 1984;68:261-7.
30. Rednam KR, Jampol LM, Levine RA, Goldberg MF. Uveal melanoma in association with multiple malignancies: a case report and review. Retina 1981;1:100-6.
31. Tucker MA, Boice JD Jr, Hoffman DA. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985;68:161-89.
32. Travis LB, Curtis RE, Boice JD Jr, Platz CE, Hankey BF, Fraumeni JF Jr. Second malignant neoplasms among long term survivors of ovarian cancer. Cancer Res 1996;56:1564-70.
33. Osterlind A, Olsen JH, Lynge E, Ewertz M. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943-80. Natl Cancer Inst Monogr 1985;68:361-88.
34. Schoenberg BS, Christine BW. Malignant melanoma associated with breast cancer. South Med J 1980;73:1493-7.
35. Greene MH, Fraumeni JF Jr. The hereditary variant of malignant melanoma. In: Clark WH Jr, Goldman LI, Mastrangelo MJ, editors. Human malignant melanoma. New York: Grune and Stratton, 1979:139-66.
36. Goldstein AM, Tucker MA. Genetic epidemiology of familial melanoma. Dermatol Clin 1995;13:605-12.
37. Cannon-Albright LA, Meyer LJ, Goldgar DE, Lewis CM, McWhorter WP, Jost M, et al. Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res 1994;54:6041-4.
38. Cannon-Albright L, Goldgar DE, Meyer LJ, et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 1993;258:1148-52.
39. Hussussian CJ, Struewing JP, Goldstein A, et al. Germline p16 mutations in familial melanoma. Nature Genet 1994;8:15-21.
40. Kamb A, Shattuck-Eidens D, Liu Q, et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 1994;8:22-6.
41. Kraemer KH, Greene MH. Dysplastic nevus syndrome: familial and sporadic precursors of cutaneous melanoma. Dermatol Clin 1985;3:225-37.
42. Seykora J, Elder D. Dysplastic nevi and other risk markers for melanoma. Semin Oncol 1996;22:682-7.
43. Goldgar DE, Cannon Albright LA, Meyer LJ, Piepkorn MW, Zone JJ, Skolnick MH. Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds. J Natl Cancer Inst 1991;83:1726-33.
44. Traupe H, Macher E, Hamm H, Happle R. Mutation rate estimates are not compatible with autosomal dominant inheritance of the dysplastic nevus 'syndrome'. Am J Med Genet 1989;32:155-7.
45. Rodriguez-Sairs RS. Ocular findings in patients with dysplastic nevus syndrome. Ophthalmology 1986;93:661-5.
46. Bataille V, Pinney E, Hungerford JL, Cuzick J, Bishop DT, Newton JA. Five cases of coexisting primary ocular and cutaneous melanoma. Arch Dermatol 1993;129:1998-201.
47. van Hees CL, Jager MJ, Bleeker JC, Kemme H, Bergman W. Occurrence of cutaneous and uveal melanoma in patients with uveal melanoma and their first degree relatives. Melanoma Res 1998;8:175-80.
48. Bataille V, Sasieni P, Cusick J, Hungerford JL, Swerdlow A, Newton-Bishop JA. Risk of ocular melanoma in relationship to cutaneous and iris naevi. Int J Cancer 1995;60:622-6.
49. Easton DF, Cox GM, Macdonald AM, Ponder BAJ. Genetic susceptibility to naevi: a twin study. Br J Cancer 1991;64:1164-7.
50. Wooster R, Neuhausen S, Mangion J, et al. Localisation of a breast cancer susceptibility gene to chromosome 13q12-q13. Science 1994;265:2088-90.
51. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676-89.
52. Sinilikova OM, Egan KM, Quinn JL, et al. Germline BRCA2 sequence variants in patients with ocular melanoma. BCLC Meeting Dublin 1998. Abstract 14.5.
53. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. The Breast Cancer Linkage Consortium. Lancet 1997;347:1505-10.
54. Wang X, Egan KM, Gragoudas ES, Kelsey KT. Constitutional alterations in p16 in patients with uveal melanoma. Melanoma Res 1996;6:405-10.
55. Tsao H, Benoit E, Sober AJ, Thiele C, Haluska FG. Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 gene. Cancer Res 1998;58:109-13.
56. Valverde P, Healey E, Jackson I, Rees JL, Thody AJ. Variants of the melanocyte stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nature Genet 1995;11:328-30.
57. Xu X, Tornwall M, Lars-Gustar L, Chhajlani V. Val92met variant of the melanocyte stimulating hormone receptor gene. Nature Genet 1996;14:384.
58. Valverde P, Healy E, Sikkink S, Haldane F, Thody AJ, Carothers A, Jackson IJ, Rees JL. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet 1996;5:1663-6.